家禽藥品市場：依產品種類、動物種類及地區分類

Poultry Pharmaceuticals Market, By Product Type, By Animal Type, and By Region

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，家禽藥品市場規模將達到 94.8 億美元，到 2033 年將達到 173.4 億美元。預計從 2026 年到 2033 年，該市場將以 9.0% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	94.8億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	9.00%	2033年市場規模預測：	173.4億美元

家禽產品，如肉類、雞肉和雞蛋，在全球廣泛消費。這些產品的需求不斷成長，而動物性蛋白質需求的持續成長是主要促進因素，預計將推動預測期內家禽藥品市場的成長。家禽數量的增加和禽類疾病的蔓延預計將推動家禽疫苗的需求。通用感染疾病病例的增加導致家禽疫苗需求激增。家禽疫苗透過顯著活化免疫系統並產生抗體來對抗入侵的病原體，有助於預防某些疾病。家禽疫苗在家禽疾病的管理和預防中發揮著至關重要的作用。大多數去活化家禽疫苗是為對抗病毒性疾病而開發的。這些疫苗的給藥途徑多種多樣，包括鼻內、口服、眼內、體內、皮下和肌肉注射。

市場動態

主要市場參與企業正致力於推出新型疫苗，以保護家禽免受馬立克氏症的侵害，預計將推動全球去活化家禽藥品市場在預測期內的成長。例如，2021年，德國勃林格殷格翰集團（一家專注於創新醫療保健產品發現、開發、生產和銷售的研髮主導企業）推出了VAXXITEK HVT+IBD+ND疫苗，用於保護家禽免受馬立克氏病、新城疫和傳染性法氏囊病（經典型和變異型）的侵害。勃林格殷格翰計劃在自有工廠生產VAXXITEK HVT+IBD+ND疫苗，該工廠每年生產超過600億劑家禽疫苗，供應美國及其他60多個國家。

本研究的關鍵特徵

本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球家禽藥品市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球家禽藥品市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
相關人員可以透過分析全球家禽藥品市場中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非
- 其他非洲地區

第7章：公司簡介

BayerAG
Bimeda
Ceva Sante Animale
Elanco Animal Health (Eli Lilly and Company)
Merck Animal Health
Merial Animal Health (Sanofi)
Virbac
Boehringer Ingelheim
Zoetis, Inc.
Pacific GeneTech
Avivagen Inc.

第8章

參考
調查方法

簡介目錄

Product Code: CMI3879

Poultry Pharmaceuticals Market is estimated to be valued at USD 9.48 Bn in 2026 and is expected to reach USD 17.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9.48 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.00%	2033 Value Projection:	USD 17.34 Bn

Poultry products such as meat, chicken, eggs, and others are widely consumed globally. Demand for these products is on the rise, moreover, increasing demand for animal-based protein is a major factor, which is expected to drive growth of the poultry pharmaceuticals market over the forecast period. The increasing poultry population and the growing prevalence of avian diseases are anticipated to enhance the demand for poultry vaccines. There is a surge in demand for poultry vaccines because of the increasing number of zoonotic cases. Poultry vaccine helps prevent a specific disease by considerably accelerating their immune system to develop antibodies to battle against the invading organisms. Poultry vaccines play a major role in poultry disease control and prevention. The majority of poultry-killed vaccines are developed to fight against viral diseases. These vaccines are administered in different forms, such as nasal, oral, ocular, vivo, subcutaneous, and intramuscular.

Market Dynamics

Key market players are focusing on launch of new vaccine to protect poutry against Marek's Disease is expected to the global inactivated poultry pharmaceuticals market growth over the forecast period. For instance, in 2021, Boehringer Ingelheim, a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products in Germany, launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Marek's Disease, Newcastle Disease, and Infectious Bursal Disease (classic and variant types). Boehringer Ingelheim will produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global poultry pharmaceuticals market based on the following parameters- Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global poultry pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry pharmaceuticals market.

Market Segmentation

Global Poultry Pharmaceuticals Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
Drugs
- VETRIMOXIN
- Other Drug Products
Vaccines
- INNOVAX
- NOBILIS
- Poulvac
- Other Vaccine Products
Feed Additives
- VIGOSINE
- Amnovit
- Other Feed Additives
Global Poultry Pharmaceuticals Market, By Animal Type (Revenue, USD Bn, 2021 - 2033)
Chicken
Turkey
Duck
Goose
Others
Global Poultry Pharmaceuticals Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Bayer AG
Bimeda
Ceva Sante Animale
Elanco Animal Health (Eli Lilly and Company)
Merck Animal Health
Merial Animal Health (Sanofi)
Virbac
Boehringer Ingelheim
Zoetis, Inc.
Pacific GeneTech
Avivagen Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product type
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Poultry Pharmaceuticals Market, By Product Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - VETRIMOXIN
  - Other Drug Products
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - INNOVAX
  - NOBILIS
  - Poulvac
  - Other Vaccine Products
Feed Additives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
  - VIGOSINE
  - ABnovit
  - Other Feed Additives

5. Global Poultry Pharmaceuticals Market, By Animal Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Chicken
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Turkey
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Duck
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Goose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Poultry Pharmaceuticals Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
North America
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa
  - Rest of Africa

7. Company Profiles

Bayer AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bimeda
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ceva Sante Animale
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elanco Animal Health (Eli Lilly and Company)
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck Animal Health
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merial Animal Health (Sanofi)
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Virbac
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zoetis, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacific GeneTech
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Avivagen Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies